Results 51 to 60 of about 18,158,432 (307)
Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. [PDF]
, 2006 We systematically reviewed the current understanding of human population immunity against SARS-CoV in different groups, settings and geography. Our meta-analysis, which included all identified studies except those on wild animal handlers, yielded an ...
Donnelly, CA +12 more
core +1 more source
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 [PDF]
, 2020 The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects
Huanyu Tao +4 more
core +1 more source
SARS-CoV-2 Sequenzdaten aus Deutschland [PDF]
, 2021 Für die Planung von Maßnahmen zur Eindämmung von COVID-19 kommt der genauen Kenntnis der Eigenschaften von SARS-CoV-2 eine zentrale Bedeutung zu. Eine besondere Rolle spielen in diesem Zusammenhang Mutationen des Virus.
Robert Koch-Institut
core +1 more source
Pediatric Discovery, 2023 Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a large, lipid‐enveloped, single‐stranded RNA virus, is a highly contagious virus that caused coronavirus disease 2019 (COVID‐19), declared a pandemic by the World Health Organization on March
Wei Xia, Zhoujie Peng
doaj +1 more source
International Journal of Biological Sciences, 2022 The ongoing COVID-19 pandemic is caused by an RNA virus, SARS-CoV-2. The genome of SARS-CoV-2 lacks a nuclear phase in its life cycle and is replicated in the cytoplasm. However, interfering with nuclear trafficking using pharmacological inhibitors greatly reduces virus infection and virus replication of other coronaviruses is blocked in enucleated ...
Chen, Mengqi, Ma, Yue, Chang, Wakam
openaire +2 more sources
Proyecto Argentino Interinstitucional de genómica de SARS-CoV-2. Reporte Nº 1 Inicial. “Análisis de secuencias de SARS-CoV-2 obtenidas de pacientes con COVID-19 de Argentina” [PDF]
, 2020 Hasta el 9 de septiembre 2021 el Proyecto a generado 26 Reportes. Reporte nro 1 - Análisis inicial. Reporte nro 2 – Patagonia. Reportes nro 3 y 4 - CABA y Prov. BsAs. Reporte nro 5 – Córdoba. Reporte nro 6 – Chaco. Reporte UK.
Consorcio Argentino de Genómica de SARS-CoV-2
core +1 more source
Therapeutic antibodies under development for SARS‐CoV‐2
View, 2022 The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma +7 more
doaj +1 more source
Australian Journal of General Practice, 2021 COVID-19 has been at the forefront of public and scientific attention since the initial report in December 2019. The kidney is one of the target organs of the causative SARS-CoV-2 virus.The aim of this article is to discuss the current understanding of COVID-19 renal disease from a primary care perspective, with the caveat that our knowledge of the ...
Titus, Thomas, Rahman, Atifur
openaire +4 more sources
Guillain‐Barré syndrome after SARS‐CoV‐2 infection
Journal of General and Family Medicine, 2022 We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita +5 more
doaj +1 more source
eLife, 2022 A new study sheds light on how SARS-CoV-2 influences the way natural killer cells can recognize and kill infected cells.
Paola Kučan Brlić, Ilija Brizić
openaire +5 more sources